CTRI/2023/06/054128已完成4 期
Active Surveillance Study of the Safety of MultiHance®in India.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Is the subject = 18 years of age?
- •2. Is the subject scheduled to undergo MRI with MultiHance® as standard of care?
- •3. Is the subject willing to provide written informed consent and comply with protocol requirements?
排除标准
- •1. Did the subject receive prior GBCA?
- •2. Was the subject already included in the study?
研究者
相似试验
进行中（未招募）
不适用
Travoprost MDPF 3 Month Safety and Efficacy StudyOpen-Angle Glaucoma or Ocular HypertensionMedDRA version: 14.1Level: HLGTClassification code 10018307Term: Glaucoma and ocular hypertensionSystem Organ Class: 10015919 - Eye disordersEUCTR2011-003851-20-SEAlcon Research, Ltd.720
尚未招募
4 期
Research on Centralized Surveillance of Safety Hospital after Shu Xuening Injection (Xue Le Tong)Adverse reactions/eventsADR/ADEITMCTR2000003536The First Affiliated Hospital of Henan University of Chinese Medicine
未知
3 期
A multicenter, investigative study of the safety and efficacy of extended administration of aripiprazole in combination with mood stabilizer for the treatment of patients with bipolar disorder experiencing a manic or mixed episodeAcute manic and mixed episodes associated with Bipolar I DisorderJPRN-jRCT2080220515Otsuka Pharmaceutical Co., Ltd.
进行中（未招募）
不适用
Study Evaluating The Safety Of Xyntha In Usual Care SettingsMedDRA version: 17.1Level: LLTClassification code 10060612Term: Hemophilia ASystem Organ Class: 100000004850Hemophilia AEUCTR2008-002456-24-Outside-EU/EEAWyeth Research12
进行中（未招募）
不适用
A Postauthorization Safety Surveillance Study of Patients Switching to ReFacto AF From ReFacto or Other Factor VIII Products in Usual Care SettingsSevere hemophilia A (FVIII: C<1%)MedDRA version: 9.1Level: LLTClassification code 10018937Term: Haemophilia AEUCTR2008-007997-39-ITWyeth Research Division of Wyeth Pharmaceuticals Inc.300